Loading organizations...
§ Private Profile · Rehovot, HaMerkaz, Israel
Cellular agriculture food technology company growing slaughter-free cultivated beef steaks from cow cells for global markets.
Based in Rehovot, Israel, Aleph Farms is a food technology company that produces cultivated beef steaks directly from non-modified cow cells using 3D tissue engineering. The cellular agriculture firm operates an asset-light business model, targets kosher-observant consumers alongside global retail markets, and employs approximately 100 to 150 people. In January 2024, the enterprise secured the world's first regulatory approval for cultivated beef from Israel's Ministry of Health and is expanding its European production capabilities through a manufacturing agreement in Switzerland. The organization has raised over $140 million in total venture capital funding from a syndicate of strategic and private equity backers, including recognizable investors such as Leonardo DiCaprio, Cargill, and L Catterton. Aleph Farms was founded in 2017 by Didier Toubia, Dr. Neta Lavon, Prof. Shulamit Levenberg, and the Strauss Group's food-tech incubator, The Kitchen Hub.
Aleph Farms has raised $117.0M across 2 funding rounds.
Aleph Farms has raised $117.0M in total across 2 funding rounds.
Aleph Farms has raised $117.0M across 2 funding rounds. Most recently, it raised $105.0M Series B in July 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 7, 2021 | $105M Series B | Mayank Singhal, Growth Fund | Lorival LUZ, Cargill, CPT Capital, Peregrine Ventures, Skyviews Life Science, Strauss Group, Thiraphong Chansiri, VisVires NEW Protein | Announced |
| May 14, 2019 | $12M Series A | Kenneth LEE | JON Nash, CPT Capital, Jesselson, M Industry, NEW Crop Capital, Peregrine Ventures, Strauss Group, Technion Innovation Opportunities Fund, U.s. Venture | Announced |
Aleph Farms has raised $117.0M in total across 2 funding rounds.
Aleph Farms's investors include Mayank Singhal, Growth Fund, Lorival Luz, Cargill, CPT Capital, Peregrine Ventures, Skyviews Life Science, Strauss Group, Thiraphong Chansiri, VisVires New Protein, Kenneth Lee, Jon Nash.